Join to access to all OVN content. Join for Free

Early release — we’re building this with you. Share your feedback

Oncology Career

Essentials

Curated books, podcasts, and articles — with one concrete move on every card.

Continuous Learning

103 cards on this shelf

Essentials · Article

Moving to industry takes a shift in thinking — and the skills you think are trivial may be your biggest asset.

The Big Idea

In a NextMinds interview, an industry leader explains that the academia-to-industry move requires a change in mindset, and that the skills PhDs consider trivial are often highly valuable in industry — and advises reaching out to people who've made the transition.

Why It Matters

Oncology researchers often undervalue exactly the skills industry needs; a mindset shift and a few informational conversations reframe the whole transition.

One Move

Reach out to two people who've made the academia-to-industry move, and ask what their day actually looks like.

Essentials · Article

Industry fellowships are a proven on-ramp — and the application cycle starts earlier than you'd think.

The Big Idea

Pharmacy Times explains how PharmD industry fellowships work as a bridge into medical affairs and beyond — with 100+ employers sponsoring, an application cycle built on early prep, interviews, and networking, and a decision day typically in mid-December.

Why It Matters

For PharmDs eyeing oncology medical affairs, a fellowship is one of the most reliable doors in — but only if you plan to the cycle's timeline.

One Move

Map the fellowship application timeline now, and start preparing months before the mid-December decision day.

Essentials · Article

Breaking into a new field isn't about what you already know — it's about believing you can learn it.

The Big Idea

In Harvard Business Review, Carol Dweck clarifies that a growth mindset means believing your talents can be developed through hard work, good strategies, and input from others — and that such people achieve more because they worry less about looking smart and put more energy into learning; nobody is purely growth-minded, so the work is spotting your fixed-mindset triggers.

Why It Matters

Career-changers entering oncology often feel they lack the “innate” background; a growth mindset turns “I don't have the experience” into “I don't have it yet.”

One Move

Catch one “I'm not good at this” thought this week, and rewrite it ending in “...yet.”

Essentials · Episode

How to repackage the experience you already have into the MSL role you want.

The Big Idea

Cherie Hyder shares with Tom Caravela how she moved from the FDA into industry by repackaging her experience — documenting it, mapping it to the MSL capability continuum, and building soft and digital skills.

Why It Matters

Many oncology professionals have the right experience but frame it wrong; learning to repackage it is what opens the door.

One Move

Reframe one past experience in MSL terms — what skill it proves — and add it to your resume.

Essentials · Article

Why you rarely find out why you didn't get the job — and how to diagnose it yourself.

The Big Idea

Caravela explains why candidates seldom get honest interview feedback (recruiters often can't or won't share it), leaving vague "not the right fit" responses — so you have to self-diagnose.

Why It Matters

Without feedback, oncology candidates repeat the same mistakes. Learning to honestly assess your own interviews is the only reliable way to improve.

One Move

Write your own honest post-mortem after your next interview — what landed, what didn't — instead of waiting for feedback that won't come.

Essentials · Episode

Cringe-worthy MSL interview fails — and exactly what to do instead.

The Big Idea

Anita Carvalho shares with Tom Caravela real MSL interview disasters and the lessons in them: preparation, handling interruptions, killing distractions, and staying professional.

Why It Matters

Learning from others' interview disasters is a cheap way for oncology candidates to avoid the same avoidable mistakes.

One Move

Eliminate one interview distraction risk — phone off, clean background — before your next virtual interview.

Essentials · Article

Why do some ideas stick and others vanish? Six traits spell SUCCESs.

The Big Idea

Chip and Dan Heath found that sticky ideas share six traits — Simple (find the core), Unexpected (break the pattern to grab attention), Concrete (use vivid, specific detail), Credible (give a reason to believe), Emotional (make people care), and Stories (let people simulate the idea) — captured in the acronym SUCCESs. The enemy is the “curse of knowledge”: experts forget what it's like not to know.

Why It Matters

Oncology professionals swim in complex data; stripping a message to a simple, concrete, story-driven core is how it survives the meeting and changes a decision.

One Move

Take one complex point you need to land, and rewrite it as a single simple, concrete sentence.

Essentials · Article

You don't rise to the level of your goals — you fall to the level of your systems.

The Big Idea

James Clear's core message: you do not rise to the level of your goals, you fall to the level of your systems. Tiny 1% improvements compound (1% better daily is roughly 37x better in a year), and lasting change is identity-based — every action is a vote for the type of person you want to become. His Four Laws make habits stick: make it obvious, attractive, easy, and satisfying.

Why It Matters

Whether building a study habit, a writing routine, or consistent KOL follow-up, oncology professionals get further by designing small repeatable systems than by setting ambitious goals they can't sustain.

One Move

Design one tiny system — a cue and a 2-minute action — for a habit you keep failing to start.

Essentials · Article

Distraction-free concentration is becoming rare — and that's exactly what makes it a superpower.

The Big Idea

Georgetown professor Cal Newport defines deep work as professional activity performed in a state of distraction-free concentration that pushes your cognitive capabilities to their limit — and argues it's both increasingly rare and increasingly valuable. Most people drift through “shallow work” (email, logistics) instead. His rules: work deeply with rituals, embrace boredom, quit distracting tools, and drain the shallows — and note that even experts sustain only about four hours of true deep work a day.

Why It Matters

Field-medical and biopharma work is a blur of email, chat, and meetings; protecting even one daily deep-work block is where the high-value thinking — a study design, a strategy, a complex analysis — actually gets done.

One Move

Block one 90-minute deep-work session tomorrow with notifications off and your phone in another room.

Essentials · Article

Why bringing Medical Affairs in early — not late — can redefine the whole drug development journey.

The Big Idea

A model for integrating Medical Affairs early in development, bridging clinical and commercial to align stakeholders, inform study design, and generate evidence that addresses market needs alongside clinical goals.

Why It Matters

For oncology MA professionals, this reframes the function from late-stage support to a strategic driver of development — a more influential, higher-value seat at the table.

One Move

Identify one development decision where MA could add value earlier than it currently does — and make the case to be in that room.

Essentials · Article

Real-world evidence increasingly decides which drugs get expanded indications and coverage.

The Big Idea

This analysis shows real-world evidence moving from nice-to-have to decisive: roughly a quarter of recent FDA labeling expansions involved RWE, making the function that generates it central to whether drugs win expanded indications and coverage — and recasting medical affairs as a commercial driver rather than a support role.

Why It Matters

Oncology lives on real-world outcomes beyond the trial; professionals who understand RWE's growing weight can position their work where the business value is concentrating.

One Move

Find one place real-world evidence could strengthen your product's value story.

Essentials · Article

Only about 1 in 8 drugs that enter clinical trials ever reaches patients — know the gauntlet your work runs.

The Big Idea

This primer lays out the five phases every therapy must clear — discovery and development, preclinical research, clinical trials, regulatory review, and post-market safety monitoring — and the sobering economics behind them: only about 12% of candidates entering clinical development reach approval.

Why It Matters

Knowing exactly where your program sits in the pipeline — and what the next phase demands — is foundational literacy for any oncology career, from the lab to the field.

One Move

Place your current project on the five-phase development map, and learn what the next phase requires.

Essentials · Book

CRISPR's promise and peril — from the scientist who invented it.

The Big Idea

Doudna explains the science of CRISPR and wrestles with its ethical stakes.

Why It Matters

As editing enters oncology, understanding both the power and the risks is part of being responsible.

One Move

Form one view on where you'd draw an ethical line on gene editing.

Essentials · Book

How US healthcare became big business — and what it costs patients.

The Big Idea

Rosenthal dissects the economics that drive American healthcare costs.

Why It Matters

Cost and access shape oncology care daily; this explains the system you operate in.

One Move

Identify one cost dynamic from the book that you see in oncology.

Essentials · Book

The immune system, told through four human stories — the basis of immuno-oncology.

The Big Idea

Richtel explains immunity through patients' lives, making a complex system human and clear.

Why It Matters

Immunotherapy is central to modern oncology; this is the most readable way to truly get the immune system.

One Move

Map one immunotherapy you encounter to the immune mechanism behind it.

Essentials · Book

A critical look at how evidence and industry can go wrong.

The Big Idea

Goldacre exposes problems in trials, publication, and marketing that distort medicine.

Why It Matters

Knowing the field's failure modes makes you a more rigorous, trustworthy oncology professional.

One Move

Pick one of Goldacre's critiques and check whether it shows up in your work.

Essentials · Book

Board-certified oncology pharmacist exam prep.

The Big Idea

A focused study resource for the BCOP certification.

Why It Matters

BCOP certification advances oncology pharmacy careers; this is the prep path.

One Move

Take a practice section and identify your two weakest domains.

Essentials · Book

Serious illness and what matters at the end — essential across cancer care.

The Big Idea

Gawande examines how medicine handles aging and dying, and how it could do better.

Why It Matters

Every oncology professional confronts mortality; this reshapes how you think about care and goals.

One Move

Reflect on one way your work could better honor what matters to patients.

Essentials · Book

A young survivor's memoir of illness and the hard road back to life.

The Big Idea

Jaouad's account of leukemia, survival, and rebuilding afterward.

Why It Matters

Survivorship is an under-seen part of the oncology journey; this gives it a voice.

One Move

Consider how your work touches the "after" of treatment, not just the treatment.

Essentials · Book

Win by making the competition irrelevant — not fighting over the same space.

The Big Idea

The authors' method for creating uncontested markets instead of bloody ones.

Why It Matters

Crowded oncology categories reward those who find uncontested space — a new indication, model, or audience.

One Move

Map where everyone competes in your area, then ask what no one is offering.

Essentials · Book

Brand strategy for pharma and medtech, demystified.

The Big Idea

Smith's accessible take on building and managing health-product brands.

Why It Matters

Commercial and marketing roles in oncology run on brand thinking; this is a clear entry.

One Move

Articulate the core brand promise of a product you work on.

Essentials · Book

A genetic disease and the science that changed its course.

The Big Idea

Trivedi tells the cystic-fibrosis story — from gene to transformative therapy.

Why It Matters

A model for how genomic understanding becomes targeted therapy — oncology's own trajectory.

One Move

Draw one parallel between the CF story and a targeted oncology therapy.

Essentials · Book

A map of industry roles — and how real people landed them.

The Big Idea

Freedman surveys the full range of biotech/pharma jobs across discovery, clinical, regulatory, and commercial.

Why It Matters

If you're eyeing industry from academia or clinic, this shows what's out there and how to get in.

One Move

Circle three roles you didn't know existed and one you'd want to learn more about.

Essentials · Book

An approachable primer on the statistics behind trials and evidence.

The Big Idea

A famously readable introduction to biostatistics and epidemiology.

Why It Matters

Oncology professionals constantly read trial stats; this demystifies them without a stats degree.

One Move

Learn what a hazard ratio really means, then re-read one trial's results.

Essentials · Book

The standard working guide to drug safety and pharmacovigilance.

The Big Idea

Cobert covers the practical world of monitoring and reporting drug safety.

Why It Matters

Pharmacovigilance is a stable, meaningful oncology path — patient safety as a profession.

One Move

Learn what an adverse-event signal is and how it's acted on.

Essentials · Book

Make better decisions by beating the biases that wreck them.

The Big Idea

The Heaths' WRAP process: widen options, reality-test assumptions, attain distance, prepare to be wrong.

Why It Matters

High-stakes oncology decisions deserve a process, not just a gut call.

One Move

Generate one more real option before locking in your next big decision.

Essentials · Book

How AI can make healthcare more human — oncology's data future.

The Big Idea

Topol explores how AI could transform diagnosis, treatment, and the clinician's role.

Why It Matters

AI is entering oncology fast; this frames the opportunity and the human stakes.

One Move

Note one task in your work AI could plausibly augment in the next few years.

Essentials · Book

The definitive clinical-oncology reference text.

The Big Idea

The comprehensive standard reference across cancer types and treatment.

Why It Matters

For oncologists and fellows, this is the field's bible.

One Move

Use it to go one level deeper on a tumor type you see often.

Essentials · Book

The Sacklers, opioids, and a hard look at the industry's incentives.

The Big Idea

Keefe's investigation of the family and company behind the opioid crisis.

Why It Matters

Every pharma professional should grapple with the industry's ethical failures; this is the cautionary text.

One Move

Name one guardrail in your own work that exists to prevent this kind of harm.

Essentials · Book

Why so many medical practices get reversed — and how to avoid building on sand.

The Big Idea

The authors examine how practices adopted without solid evidence later get overturned.

Why It Matters

Oncology adopts fast; understanding reversal makes you a more careful interpreter of new data.

One Move

Identify one practice you assume is settled and check the evidence behind it.

Essentials · Book

Once you're in the seat — how to actually be great at the job.

The Big Idea

A practical guide to the craft of the role: KOL engagement, scientific exchange, and the field activities that define a strong MSL.

Why It Matters

Landing the role is half the battle; the MSLs who get promoted master KOL relationships and scientific exchange early. In oncology's KOL-dense landscape, that compounds fast.

One Move

Write the one scientific question you genuinely want a KOL's view on before your next meeting — and lead with it.

Essentials · Book

The high-stakes inside story of building a blockbuster cancer drug.

The Big Idea

Vardi chronicles the race, money, and people behind a breakthrough oncology therapy.

Why It Matters

It shows how oncology drugs actually get made and commercialized — the business reality behind the science.

One Move

Note one thing the story teaches about how science becomes a product.

Essentials · Book

Drug process development and manufacturing, made accessible.

The Big Idea

Harrison explains how a molecule scales from lab to commercial production.

Why It Matters

CMC and manufacturing are under-appreciated oncology career tracks; this opens the door.

One Move

Learn one reason scaling up a process is harder than it sounds.

Essentials · Book

The classic on how clinical trials are designed and conducted.

The Big Idea

The standard reference on trial design, conduct, analysis, and interpretation.

Why It Matters

Trials are the engine of oncology evidence; understanding their design makes you sharper.

One Move

Learn superiority vs. non-inferiority designs, then spot one in a recent oncology trial.

Essentials · Book

Value, pricing, and reimbursement across global health systems.

The Big Idea

A primer on how drugs get paid for — HTA, pricing, and access strategy.

Why It Matters

Market access decides whether a great oncology drug reaches patients; it's a fast-growing track.

One Move

Learn how one oncology drug is reimbursed in one market you care about.

Essentials · Book

How the first biotech was built, where science met venture capital.

The Big Idea

Hughes documents Genentech's founding and the birth of the biotech industry.

Why It Matters

Understanding biotech's origins helps you read today's industry — useful for BD, strategy, or the curious.

One Move

Note one lesson from Genentech's founding relevant to today's oncology biotech.

Essentials · Book

How genetics and genomics shape modern medicine.

The Big Idea

A clear textbook connecting genomic science to clinical practice.

Why It Matters

Precision oncology runs on genomics; this is the grounding for diagnostics and biomarker work.

One Move

Learn how one biomarker test guides an oncology treatment decision.

Essentials · Book

What real strategy looks like — and how to spot the fluff.

The Big Idea

Rumelt strips strategy down to diagnosis, a guiding policy, and coherent action.

Why It Matters

Oncology plans are often goals dressed as strategy; this teaches the difference.

One Move

Test one current "strategy": does it have a clear diagnosis and coherent actions?

Essentials · Book

A practical guide for new investigators starting their labs.

The Big Idea

A widely used handbook on launching and managing an academic research career.

Why It Matters

For early oncology investigators, it's a trusted, free-to-find roadmap.

One Move

Pick one chapter matching your current challenge and act on it.

Essentials · Book

A provocative critique of oncology trials, evidence, and value.

The Big Idea

Prasad challenges how cancer drugs are tested, approved, and priced.

Why It Matters

It sharpens your critical eye on the very evidence oncology runs on — uncomfortable but essential.

One Move

Pick one of Prasad's critiques and decide whether you agree.

Essentials · Book

For nurses navigating the clinical-trial world — the OCRN role.

The Big Idea

An ONS guide to the specialized role of the oncology clinical research nurse.

Why It Matters

Clinical research nursing is a growing oncology niche bridging care and trials.

One Move

Decide whether the research-nurse path fits your interests.

Essentials · Book

A portable clinical-oncology handbook for the day-to-day.

The Big Idea

A concise, practical bedside reference for clinical oncology.

Why It Matters

The everyday companion to the big reference — fast answers in clinic.

One Move

Keep it handy and use it on your next tricky case.

Essentials · Book

The go-to framework for pharma marketing planning.

The Big Idea

Smith's structured approach to building rigorous pharma marketing plans.

Why It Matters

For oncology marketers, this is the discipline behind a credible plan.

One Move

Draft a one-page skeleton plan for a product using Smith's structure.

Essentials · Book

The classic plain-English map of the FDA drug-approval process.

The Big Idea

Mathieu walks through how drugs get from IND to approval.

Why It Matters

Understanding the approval path clarifies timelines and decisions across every oncology function.

One Move

Trace one oncology drug you know through the approval stages Mathieu describes.

Essentials · Book

The foundational reference on the psychological care of cancer patients.

The Big Idea

The field-defining text on psycho-oncology, founded by Holland.

Why It Matters

The emotional dimension of cancer is real care, not a soft add-on; this is the discipline's anchor.

One Move

Learn one psycho-oncology concept you can apply in patient interactions.

Essentials · Book

The field-standard reference for regulatory professionals.

The Big Idea

The RAPS series covers the core knowledge of drug and device regulation.

Why It Matters

Regulatory is a major oncology career track; this is the recognized foundation.

One Move

Skim the contents and identify the regulatory area you'd most want to specialize in.

Essentials · Book

A reference covering manufacturing controls and regulatory filings.

The Big Idea

A comprehensive text on regulatory and quality across the product lifecycle.

Why It Matters

Quality and CMC roles intersect regulation constantly; this connects the two.

One Move

Note how a manufacturing change triggers regulatory work.

Essentials · Book

Predictive, data-rich, personalized medicine — where care is heading.

The Big Idea

Hood and Price argue for a shift to proactive, data-driven health.

Why It Matters

Precision and prevention are reshaping oncology; this frames the data-first future.

One Move

Note one way proactive data could change early cancer detection in your area.

Essentials · Book

How people find — and lose — hope through illness.

The Big Idea

Groopman, an oncologist, explores the role of hope in facing disease.

Why It Matters

Hope is part of oncology care; this examines it honestly, without false cheer.

One Move

Reflect on how you talk about hope with patients — and whether it's honest.

Essentials · Book

Drug discovery and biotech-startup life, up close.

The Big Idea

Werth's classic account of Vertex's early years and the gamble of drug discovery.

Why It Matters

For anyone curious about biotech, this captures the obsession, risk, and grind of making a new medicine.

One Move

Decide whether the startup-science life appeals to you — and why.

Essentials · Book

Living fully while dying of cancer — a luminous memoir.

The Big Idea

Riggs writes about finding meaning and ordinary joy in terminal illness.

Why It Matters

It deepens empathy for what patients carry day to day.

One Move

Carry one of Riggs's reflections into your next patient or family interaction.

Essentials · Book

Why checklists save lives in complex, high-stakes work.

The Big Idea

Gawande shows how simple checklists prevent catastrophic errors in medicine and beyond.

Why It Matters

Oncology's complexity is exactly where checklists prevent harm — for clinicians and quality roles alike.

One Move

Build a short checklist for one error-prone task you do regularly.

Essentials · Book

Jennifer Doudna, CRISPR, and the gene-editing revolution.

The Big Idea

Isaacson's biography of Doudna and the race to harness CRISPR.

Why It Matters

Gene editing is moving into oncology fast; this is the accessible inside story of how it arrived.

One Move

Identify one way gene editing could touch your area in the next five years.

Essentials · Book

A pioneer's history of the war on cancer — and where it's headed.

The Big Idea

DeVita, a chemotherapy pioneer, recounts the fight against cancer and the system's flaws.

Why It Matters

From one of the field's architects, this is insider context on how oncology got here and what still blocks progress.

One Move

Note one systemic barrier DeVita names that you recognize in your own work.

Essentials · Book

Concept to launch — the whole drug journey, concisely.

The Big Idea

Harrison gives a clear overview of how a molecule becomes a medicine.

Why It Matters

Whatever function you're in, seeing the full pipeline helps you understand where your work fits.

One Move

Locate your role on the development cycle and note who's upstream and downstream of you.

Essentials · Book

Anticancer drugs, dosing, and toxicities — explained simply.

The Big Idea

A straightforward reference to oncology pharmacology.

Why It Matters

A clear pharmacology grounding serves pharmacists, nurses, and MSLs alike.

One Move

Review the mechanism and key toxicities of one drug class you encounter.

Essentials · Book

The Pulitzer-winning "biography of cancer" — essential context for everyone in oncology.

The Big Idea

Mukherjee traces cancer from ancient times to modern medicine in a sweeping narrative.

Why It Matters

Whatever your role, this is the shared story of the disease you work on — the context that makes the work make sense.

One Move

Read the prologue this week; it reframes why the field exists.

Essentials · Book

The story of heredity — from Mendel's peas to the gene-editing era.

The Big Idea

Mukherjee tells the history and science of the gene and its power over life and medicine.

Why It Matters

Genomics now drives oncology; this gives the deep context behind targeted therapy and precision medicine.

One Move

Note one way the gene's story connects to a therapy you work on or near.

Essentials · Book

A practical road map to writing fundable research grants.

The Big Idea

Lai gives a step-by-step system for planning and writing competitive grants.

Why It Matters

Funding is the lifeblood of oncology research careers; grant skill is career-defining.

One Move

Draft one specific aim for a project using Lai's structure.

Essentials · Book

The HeLa story — a touchstone on consent, ethics, and the people behind the science.

The Big Idea

Skloot tells the story of Henrietta Lacks, whose cells transformed research without her knowledge.

Why It Matters

Research ethics and patient dignity sit at oncology's core; this is the human reminder behind the cell line.

One Move

Reflect on one place your work touches patient consent or data — and whether it honors the person.

Essentials · Book

Why great organizations get disrupted — and how not to.

The Big Idea

Christensen's theory of disruptive innovation and why incumbents miss it.

Why It Matters

Oncology is being disrupted — new modalities, diagnostics, AI; this helps you see what's coming.

One Move

Ask what "good enough but cheaper/simpler" innovation could upend your corner of oncology.

Essentials · Book

Build-measure-learn — how to launch the new without betting it all.

The Big Idea

Ries' method of validated learning, MVPs, and fast iteration for new ventures.

Why It Matters

Biotech founders and intrapreneurs in oncology can test ideas cheaply before scaling.

One Move

Define the smallest experiment that would test your riskiest assumption.

Essentials · Book

A plain-English tour of what the MSL role actually is — for anyone weighing the move.

The Big Idea

Albert walks the role end to end — what the job involves day to day, who it suits, and how it fits inside Medical Affairs.

Why It Matters

Plenty of oncology clinicians and scientists are MSL-curious but don't actually know what the role entails. This answers that before you spend months chasing it.

One Move

Write one honest sentence on whether the day-to-day genuinely fits you — and why.

Essentials · Book

Digital medicine and the rise of the empowered patient.

The Big Idea

Topol argues data and devices are shifting power toward patients.

Why It Matters

Oncology patients are more informed and connected than ever; this reframes the relationship.

One Move

Consider one way your work could better serve a more empowered patient.

Essentials · Book

Healthcare costs, hidden prices, and the push for transparency.

The Big Idea

Makary investigates the money games in healthcare and the movement to fix them.

Why It Matters

Oncology is among the costliest care; understanding pricing makes you a better advocate.

One Move

Find out the real cost of one thing you order or recommend.

Essentials · Book

Cell biology as story — the foundation under all of modern medicine.

The Big Idea

Mukherjee explores the cell, from discovery to cell therapies, in narrative form.

Why It Matters

Cell and gene therapies are reshaping oncology; this grounds you in the biology behind the breakthroughs.

One Move

Pick one cell-therapy concept you half-understand and let this fill it in.

Essentials · Book

A neurosurgeon's reflection on living and dying, written as he faced cancer.

The Big Idea

Kalanithi's memoir of facing terminal illness as both doctor and patient.

Why It Matters

It puts you in the patient's chair — a perspective every oncology professional needs.

One Move

Note one assumption about patients this book changes for you.

Essentials · Book

Building something genuinely new — not just copying what works.

The Big Idea

Thiel on creating breakthrough (0 to 1) value rather than incremental (1 to n) improvement.

Why It Matters

Oncology's biggest wins come from true novelty; this challenges how you think about moats.

One Move

Ask what important truth about your field few people agree with you on.

Essentials · Episode

Why business acumen is the MSL's other essential currency — beyond the science.

The Big Idea

Maria Abunto and Nabhan Islam explore with Tom Caravela the role of business acumen in medical affairs — defining it, mastering the language, and demonstrating it as an MSL.

Why It Matters

Scientific skill alone plateaus an oncology MSL career; business acumen is what earns a seat at the strategy table.

One Move

Learn one piece of your company's commercial strategy well enough to connect your field work to it.

Essentials · Episode

How MSLs bring real value — and when in development they bring it most.

The Big Idea

Steven Stein of Arena Pharmaceuticals explores with Tom Caravela the value of the MSL role — early KOL engagement, strategic timing in drug development, and overcoming internal challenges.

Why It Matters

Oncology MSLs add the most value when engaged early and strategically; understanding this elevates how you position the role.

One Move

Identify one way to demonstrate your value earlier in your therapy's development cycle.

Essentials · Episode

When should MSLs get involved in drug development? Earlier than you think.

The Big Idea

Jeff Vaughn and Dean McAllister explore with Tom Caravela the timing of MSL involvement in drug development — debunking misconceptions and showing the value of early engagement.

Why It Matters

Early MSL involvement adds strategic value in oncology development; knowing the right timing elevates the role.

One Move

Identify one development stage where MSL input could add value earlier than it currently does.

Essentials · Episode

How MSLs can use real-world evidence to deepen their scientific impact.

The Big Idea

Elizabeth Pash shares with Tom Caravela how MSLs leverage real-world evidence — increasingly accepted since the 21st Century Cures Act — to enrich understanding beyond clinical trials.

Why It Matters

RWE is reshaping oncology evidence; MSLs fluent in it bring more to KOL conversations and medical strategy.

One Move

Learn one real-world evidence study in your therapeutic area well enough to discuss it with a KOL.

Essentials · Episode

How market access intersects with the MSL role — and why it matters.

The Big Idea

Ruchit Parikh shares with Tom Caravela the role of market access in pharma — how it intersects with MSL work, common knowledge gaps, and resources to close them.

Why It Matters

Market access shapes whether oncology therapies reach patients; MSLs who understand it bring more to the table.

One Move

Learn the basics of how your therapy gets reimbursed, so you can speak to access when it comes up.

Essentials · Article

By 2030, most of the workforce will need reskilling — the curious learners stay ahead.

The Big Idea

The WEF estimates that if the global workforce were 100 people, 59 would need reskilling by 2030 — and 85% of employers plan to upskill their teams, with AI and big data the fastest-growing skill area. The report pairs technological literacy and prompt-writing with curiosity and lifelong learning as the combination that future-proofs a career: the people who keep learning to work with AI stay ahead of those who wait.

Why It Matters

Oncology is being reshaped by AI in discovery, trials, and medical affairs; professionals who invest a few hours a week in hands-on AI fluency now will be the ones trusted to lead its adoption.

One Move

Schedule two hours a week to build AI fluency — experiment with a tool on real work.

Essentials · Article

AI states wrong answers as confidently as right ones — in regulated medical work, that's a risk.

The Big Idea

Large language models hallucinate — generating plausible-sounding but incorrect information presented as fact — which makes human oversight non-negotiable in regulated medical work. A medical-affairs review notes AI can accelerate content and analysis, but every claim still needs expert validation against approved sources, and only a small share of life-science companies have so far moved AI into medical affairs at scale.

Why It Matters

In oncology, an unverified AI error in a medical-information response or a slide isn't just embarrassing — it's a patient-safety and compliance risk, so the clinician's judgment remains the essential final check.

One Move

Fact-check every AI-generated medical claim against an approved source before it leaves your hands.

Essentials · Episode

Where AI is actually landing in Medical Affairs — and the skills that suddenly matter.

The Big Idea

Tom Caravela and Patrina Pellett report from an AI in Medical Affairs conference, covering real use cases — content, training, predictive analytics, insights — and the rising value of prompt engineering and custom GPTs.

Why It Matters

AI is reshaping oncology medical affairs fast; the professionals who learn where it adds value — and build the skills — stay ahead of the curve.

One Move

Pick one repetitive MA task and experiment with an AI tool to handle it this week.

Essentials · Episode

How AI and machine learning will reshape the MSL role — from the field to the job search.

The Big Idea

Dr. Sanjay Singhvi explores with Tom Caravela how AI is transforming medical affairs — practical MSL applications, manager-level trend analysis, and even resume optimization for job seekers.

Why It Matters

AI is changing oncology medical affairs and hiring; MSLs who learn its applications stay valuable as the field shifts.

One Move

Try one AI tool this week — for a field task or your resume — and see where it helps.

Essentials · Episode

How AI digital twins could speed up clinical trials — from an oncologist-author.

The Big Idea

Dr. Chadi Nabhan shares with Michael Pietrack how AI digital twins can accelerate clinical trials and cut costs, plus lessons from mentorship and a multifaceted oncology career.

Why It Matters

AI is reshaping oncology trials; understanding innovations like digital twins keeps you ahead of where the field is heading.

One Move

Learn one way AI is changing clinical trials in your therapeutic area.

Essentials · Episode

How AI augments the everyday MSL — cutting prep time and sharpening work.

The Big Idea

Nandini Sabharwal of Pfizer shares with Tom Caravela how AI augments daily MSL life — reducing prep time, aiding HCP meeting prep, and supporting advisory board planning.

Why It Matters

AI is becoming a daily oncology MSL tool; using it well frees time for the human work that matters most.

One Move

Use a generative AI tool to prep for one upcoming meeting, and judge what it saved you.

Essentials · Episode

What the metaverse could mean for Medical Affairs — opportunity or hype?

The Big Idea

Bruno Larvol explores with Tom Caravela the metaverse's potential for medical affairs — future applications for MSLs, the opportunities and challenges, and growing pharma interest.

Why It Matters

Emerging tech reshapes oncology engagement; staying literate on the metaverse keeps you ahead of where KOL interaction may head next.

One Move

Spend 30 minutes learning one emerging-tech trend, like the metaverse, that could touch your field in five years.

Essentials · Article

“Follow your passion” may be the worst career advice — build rare skills first, and passion follows.

The Big Idea

Cal Newport argues that “follow your passion” is dead wrong: most people have no pre-existing passion to match to a job, and a passion mindset makes you hyperaware of what you dislike, especially early on. Instead, build “career capital” — rare and valuable skills — then trade it for the autonomy and control that make work meaningful; passion grows from mastery, not before it.

Why It Matters

Early-career oncology roles are heavy on grunt work; the craftsman mindset — getting so good they can't ignore you — is what eventually unlocks the autonomy and influence you actually want.

One Move

Pick one rare, valuable skill in your field and deliberately practice it until you're known for it.

Essentials · Book

Growth vs. fixed mindset — and why it shapes how far you go.

The Big Idea

Dweck shows that believing abilities can grow drives learning, resilience, and achievement.

Why It Matters

Oncology evolves fast; a growth mindset keeps you learning instead of clinging to what you know.

One Move

Catch one "I'm not good at this" thought today and add the word "yet."

Essentials · Episode

How MSLs drive clinical trial success — from site selection to recruitment.

The Big Idea

Khalil Ahmed explores with Tom Caravela the MSL's growing role in clinical trials — site selection, recruitment, training — and the financial cost of delays, illustrated by a Lipitor case study.

Why It Matters

Trial delays are enormously costly in oncology; MSLs who support trials well add measurable strategic value.

One Move

Learn how your field work could support one active trial's site selection or recruitment.

Essentials · Episode

The psychology of keeping the promises you make to yourself — and why it changes everything.

The Big Idea

Tom Caravela explores self-commitment: how promises to yourself, backed by a real plan and execution, drive success — and how to beat the cognitive traps that derail them.

Why It Matters

Career growth in oncology rests on follow-through; learning to keep your own commitments is the foundation everything else builds on.

One Move

Make one specific promise to yourself this week, write the plan to keep it, and execute the first step today.

Essentials · Episode

Ten lessons from "Think Again" for the MSL mindset — starting with intellectual humility.

The Big Idea

Jeff Vaughn and Tom Caravela apply Adam Grant's "Think Again" to the MSL role — intellectual humility, unlearning, and balancing certainty with uncertainty.

Why It Matters

Oncology evidence shifts constantly; the MSLs who can rethink gracefully stay credible and current.

One Move

Identify one strong opinion you hold in your field and ask what evidence would change it.

Essentials · Episode

How to move from MSL to MSL leader — and know when you're ready.

The Big Idea

Kathy Gann shares with Tom Caravela the MSL-to-leader transition — personal development, goal setting, lifelong learning, and recognizing the right time to step into management.

Why It Matters

The leap to leadership is a pivotal oncology career step; knowing when and how to make it sets you up to succeed.

One Move

Identify one leadership skill to build now, before you're in the role that requires it.

Essentials · Article

You can't think your way into a new career — you act your way into one.

The Big Idea

Herminia Ibarra's research on career changers overturns conventional advice: rather than analyzing your “true self” first and then leaping, successful reinvention comes from acting — running small “identity experiments,” trying on “possible selves,” building new networks, and letting clarity emerge from doing rather than introspection.

Why It Matters

Oncology professionals weighing a pivot — bench science to field medical, MSL to commercial — often wait for a certainty that never comes; small experiments reveal the right path faster than any self-assessment.

One Move

Design one small, low-risk experiment to test a possible next role — a project, a shadow day, a side assignment.

Essentials · Episode

How to survive — and thrive — after a layoff in medical affairs.

The Big Idea

Carol Lawlor shares with Tom Caravela how she weathered industry layoffs, offering resilient job-search strategies and a look at emerging roles in medical affairs.

Why It Matters

Layoffs are a recurring oncology reality; resilience and an eye for emerging roles turn a setback into a pivot.

One Move

Identify one emerging role in medical affairs your skills could transfer into, and start learning about it.

Essentials · Article

Talent matters, but sticking with your goals for years — through setbacks — matters more.

The Big Idea

Psychologist Angela Duckworth found that a powerful predictor of success isn't talent or IQ but grit — passion and perseverance for very long-term goals. Across West Point cadets, students, and salespeople, the grittiest people treated life like a marathon, not a sprint: they stuck with their goals day in, day out, for years, and stayed willing to fail, learn, and start over. A growth mindset — believing ability can grow with effort — helps build it.

Why It Matters

Oncology careers are long and full of setbacks — failed trials, rejected papers, missed promotions; the professionals who advance are usually the ones who persevere through the dips, not the most naturally gifted.

One Move

Pick one long-term goal and commit to one small action toward it every week, especially after a setback.

Essentials · Article

Harsh self-criticism isn't what drives you — self-compassion is the better motivator.

The Big Idea

Researcher Kristin Neff defines self-compassion as treating yourself with the same kindness you'd offer a good friend who's struggling, built on three elements: self-kindness (versus self-judgment), common humanity (everyone fails and falls short), and mindfulness (acknowledging pain without exaggerating it). Her research shows self-criticism activates the stress response, while self-compassion engenders a learning and growth orientation that actually improves performance.

Why It Matters

After a mistake or a rejection, oncology professionals recover and learn faster by treating themselves like a respected colleague than by piling on harsh self-criticism.

One Move

Write what you'd say to a friend in your shoes after a setback — then say it to yourself.

Essentials · Article

It's not how much you practice — it's whether you're practicing the right way.

The Big Idea

Psychologist Anders Ericsson found that what separates experts isn't innate talent but how they practice. Naive practice (mindless repetition) plateaus; purposeful and deliberate practice work because they set specific goals, demand full focus, push just past the comfort zone, and use feedback to correct course — building richer mental models. Plateaus signal a need to change methods, not a ceiling.

Why It Matters

Whether sharpening a presentation or a clinical skill, oncology professionals improve fastest by targeting a specific weakness with feedback, not by logging more comfortable repetitions.

One Move

Pick one specific weakness, set a clear goal, and drill it with feedback at the edge of your ability.

Essentials · Article

“I can't do this” becomes “I can't do this yet” — and that changes everything.

The Big Idea

Stanford psychologist Carol Dweck distinguishes a fixed mindset (abilities are static) from a growth mindset (abilities can be developed through effort). Her emblem is the power of “yet”: a Chicago school replaced failing grades with “not yet,” reframing failure as a point on a learning curve. Brain studies show growth-mindset learners engage with their errors and learn from them, and mindsets can be deliberately changed.

Why It Matters

Oncology and biopharma move fast; treating a knowledge gap or a stumble as “not yet” rather than “not able” is what keeps professionals learning instead of retreating to what they already know.

One Move

Catch yourself saying “I can't do this” and add the word “yet” — then identify your next learning step.

Essentials · Article

Your brain learns in two gears — and knowing when to switch makes hard things easier.

The Big Idea

Engineering professor Barbara Oakley translates neuroscience into study tactics: the brain toggles between a focused mode (concentrated problem-solving) and a diffuse mode (relaxed, connection-making — sparked by breaks, walks, and sleep). Learning means building “chunks” through focused attention plus practice, and avoiding the illusion of competence that rereading and highlighting create. Use short focused sprints, then step away to let ideas settle.

Why It Matters

Cramming clinical material the night before fails; oncology professionals retain more by alternating focused study with real breaks that let the diffuse mode consolidate.

One Move

Study in focused 25-minute blocks, then take a real break to let your diffuse mode connect the dots.

Essentials · Article

The study habits that feel productive — rereading, highlighting — are the ones that don't work.

The Big Idea

Cognitive scientists Brown, Roediger, and McDaniel show that the study habits that feel productive — rereading and highlighting — create an illusion of mastery but don't last. What works is harder: retrieval practice (quiz yourself from memory), spacing (leave time to forget, then recall), and interleaving (mix problem types). These “desirable difficulties” feel slower but build durable, transferable knowledge.

Why It Matters

Oncology professionals absorb enormous volumes of evolving clinical data; self-testing and spaced review retain it far better than the rereading most people default to.

One Move

Quiz yourself from memory instead of rereading, and space your review sessions over days, not one cram.

Essentials · Article

In a world obsessed with specializing early, breadth is an underrated superpower.

The Big Idea

Science writer David Epstein challenges the cult of early specialization: in “wicked” domains with unclear rules, generalists who sample widely, take detours, and think across fields often outperform narrow specialists. Breadth fuels analogical thinking — applying an idea from one domain to another — and makes people more adaptable when the rules change.

Why It Matters

A career spanning clinical, commercial, and scientific terrain isn't a liability in oncology — the cross-domain perspective is exactly what lets you connect dots specialists miss.

One Move

Take on one project outside your specialty this year to build range and make cross-domain connections.

Essentials · Article

If you can't explain it simply, you don't understand it yet.

The Big Idea

Named after physicist Richard Feynman, this technique tests real understanding: pick a concept, explain it in plain language as if teaching a beginner, notice where your explanation breaks down, then go back to the source to fill those gaps — and repeat until it's simple and complete. The difficulty of explaining reveals the limits of what you actually understand.

Why It Matters

If you can't explain a mechanism of action or a trial design simply to a colleague, you don't fully own it yet; teaching it plainly is how oncology professionals turn exposure into mastery.

One Move

Explain a concept you're learning in plain language as if teaching a beginner — your gaps will surface fast.

Essentials · Article

When you need a hard skill fast, an intense self-directed sprint beats waiting for a class.

The Big Idea

Scott Young documents how “ultralearners” acquire hard skills fast through aggressive, self-directed projects guided by nine principles — including metalearning (map the subject first), directness (practice in the real context where you'll use the skill, which solves the transfer problem), drilling your weakest points, and testing yourself. The thread: intensity and strategy beat passively sitting through classes.

Why It Matters

When a new therapeutic area, modality, or tool lands on your desk, an ultralearning sprint — directed and direct — gets an oncology professional functional far faster than waiting for formal training.

One Move

Define one skill you want, then practice it directly in the real context where you'll use it.

Essentials · Episode

What digital therapeutics are — and what they mean for the MSL role.

The Big Idea

Madleine Makori shares with Tom Caravela the world of digital therapeutics — the differentiation, the challenges, and how COVID accelerated adoption and provider interest.

Why It Matters

Digital therapeutics is an emerging oncology-adjacent space; understanding it positions MSLs for a growing field.

One Move

Spend 20 minutes learning what digital therapeutics exist in or near your therapeutic area.

Essentials · Episode

How MSL training is evolving — and the skills that matter most now.

The Big Idea

Michael Parisi and Marissa Polly explore with Tom Caravela the evolving training needs of MSLs — scientific and clinical skills, plus the soft skills and empathy that drive success.

Why It Matters

Continuous training keeps oncology MSLs sharp; knowing where the field is investing tells you where to grow.

One Move

Identify one scientific and one soft skill to develop, and find a training resource for each.

Essentials · Episode

Three surprising ways podcasts can level up your MSL career.

The Big Idea

Sarah Snyder shares with Tom Caravela why MSLs should engage with podcasts — for professional growth, staying informed, and connecting with thought leaders.

Why It Matters

Podcasts are a low-effort way for busy oncology MSLs to keep learning and stay current.

One Move

Add one career-relevant podcast to your routine, and apply one idea from it each week.

Essentials · Episode

The MSL's secret weapon — the art of asking powerful questions.

The Big Idea

Mary Winkels of Vertex shares with Tom Caravela the MSL "secret weapon" for insightful engagement — building curiosity and the question-asking muscle that most MSLs underuse.

Why It Matters

The best oncology MSLs ask better questions; this is the under-developed skill that unlocks richer KOL engagement.

One Move

Prepare one powerful, open-ended question for your next KOL meeting — and let the KOL do most of the talking.

Essentials · Episode

Why continuous learning is the engine of a resilient career.

The Big Idea

John Pracyk, a Chief Medical Safety Officer, shares with Tom Caravela how continuous learning drives adaptability and advancement — and how to fit small daily learning into a busy life.

Why It Matters

Oncology moves fast; professionals who keep learning stay versatile and resilient as the field changes.

One Move

Schedule one small daily learning session — 15 minutes — and protect it this week.

Essentials · Episode

How to build the lifelong-learner mindset that keeps MSL careers growing.

The Big Idea

Sarah Snyder shares with Tom Caravela how MSLs can become lifelong learners — personal accountability, managing decision fatigue, and setting achievable learning goals.

Why It Matters

Oncology evolves constantly; the lifelong-learner mindset is what keeps MSLs relevant year after year.

One Move

Set one achievable learning goal this month, and start before you feel fully ready.

All Essentials shelves